Year: 2023

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN THE UNITED STATES, CANADA, AUSTRALIA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES Oslo, 14 November 2023 – Reference is made to the announcement made by BW Sirocco Holdings AS (the “Offeror) on 9 November 2023 regarding a recommended voluntary offer to acquire all the issued and outstanding shares (the “Shares“) in BW Ideol AS (“BW Ideol” or the “Company“), not already held by the Initiating Shareholders (as defined below), at an offer price of NOK 12 per Share (the “Offer Price“), to be settled in cash or shares in the Offeror (the “Offer“)....

Golden Ocean Group Limited (the “Company) will publish its financial results for the third quarter of 2023 on Tuesday November 21, 2023. In connection with the release, a conference call and webcast will be held as described below: Conference call and webcastA conference call will be held at 3:00 P.M. CET (9:00 A.M. New York Time) on Tuesday November 21, 2023. The presentation will be available for download from the Investor Relations section at www.goldenocean.bm (under “Presentations”) prior to the conference call/webcast. In order to listen to the presentation, you may do one of the following: a. WebcastVisit the Investor Relations section of the Company’s website at www.goldenocean.bm and click on the link to “Webcast”, or access directly via the webcast link below. GOGL Q3 2023 Webcast b. Conference CallParticipants will...

The collaboration expands Absci’s de novo AI drug creation portfolio into dermatology and accelerates discovery for broader chronic inflammatory diseases VANCOUVER, Wash. and BARCELONA, Spain, Nov. 14, 2023 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, and Almirall S.A. (BME: ALM), a global biopharmaceutical company focused on medical dermatology, today announced a drug discovery partnership aimed to develop and commercialize AI-designed therapeutics to fight chronic and debilitating dermatological diseases. The partnership combines Absci’s Integrated Drug Creation™ platform with Almirall’s dermatological expertise with the goal of delivering life-changing medicines to patients, marking another step forward in AI drug creation. The partnership represents Almirall’s first de novo...

ST HELIER, Jersey, Nov. 14, 2023 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or the “Company”) (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) announces its operating and financial results for the quarter and the nine months ended September 30, 2023 (the “Quarter” and “nine months” respectively).  Further information on the financial and operating results for the Quarter and nine months can be found in the management discussion and analysis (“MD&A”) and the unaudited financial statements, which are available on the Company’s website and are being filed on SEDAR.  This Quarter’s results demonstrate a significant improvement in the production performance of Blanket Mine (“Blanket”), which reported record quarterly production. This Quarter was...

Sale of majority stake to Glencore at implied enterprise value of US$9.0 billion on a 100% basis Minority sale to Nippon Steel Corporation Proceeds will be used to strengthen Teck’s balance sheet, return cash to shareholders and ensure Teck is well positioned to realize value from its copper growth portfolio Teck to retain all steelmaking coal cash flows until expected closing in third quarter of 2024 Glencore to establish Canadian head office for the steelmaking coal business in Vancouver, maintain jobs and increase investment in the business and local communitiesVANCOUVER, British Columbia, Nov. 13, 2023 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) today announced it has agreed to sell its entire interest in its steelmaking coal business, Elk Valley Resources (“EVR”), through a sale...

AB „Ignitis grupė” (hereinafter – the Group) will release its results for the first nine months of 2023 on Tuesday, 21 November 2023. It will be followed by an earnings call for investors and analysts to be held on the same day at 1:00 pm Vilnius / 11:00 am London time. To join the earnings call, please register at: https://edge.media-server.com/mmc/p/nyw4cuus/  It will be also possible to join the earnings call by phone. To access the dial-in details please register here. After completing the registration, you will receive dial-in details on screen and via email. You will be able to dial in using the provided numbers and the unique pin or by selecting ‘Call me’ option and providing your phone details for the system to connect you in automatically as the earnings call starts. All questions can be directed in advance to the Group’s...

Honkarakenne LtdPress release14 November 20239.00 am Honka log house to have the world’s first roof made of fossil-free steel Honkarakenne and Ruukki Construction, which is part of SSAB Group, are collaborating in a pilot project on the use of fossil-free steel in roofing products. The project serves as an example of collaboration between two companies committed to reducing the environmental burden, aiming to create carbon-neutral buildings and make the construction sector more sustainable. The Honka log home being built in a beautiful, rural setting in Klaukkala, Finland, will be the world’s first building with a roof made of fossil-free steel. Honka’s new log-built detached house will be topped with a Ruukki Classic roof made of fossil-free steel, based on the HYBRIT technology, at Ruukki Construction’s plant in Vimpeli, Finland. The...

Aktia Bank Plc Stock Exchange Release 14 November 2023 at 9.00 a.m. Aktia Bank Plc: Managers’ Transactions – Uki Lammi Person subject to the notification requirement Name: Lammi, Uki Position: Other senior manager Issuer: Aktia Bank plc LEI: 743700GC62JLHFBUND16 Notification type: INITIAL NOTIFICATION Reference number: 743700GC62JLHFBUND16_20231109133438_162 ____________________________________________ Transaction date: 2023-11-09 Venue not applicable Instrument type: SHARE ISIN: FI4000058870 Nature of the transaction: SUBSCRIPTION Transaction details (1): Volume: 1100 Unit price: 8.18 EUR Aggregated transactions (1): Volume: 1100 Volume weighted average price: 8.18 EUR Aktia Bank Plc Further information: Mia Smeds, Communications Director, tel. +358 44 546 0379 Distribution: Nasdaq Helsinki Ltd Mass media www.aktia.com Aktia is a Finnish...

Presentation will highlight versatility of DARPin designs in enabling conditional activation of the immune system to fight tumors, addressing toxicities seen with other targeted modalitiesReview includes differentiated mechanisms of action including tumor-localized activation, avidity-driven selectivity and novel SWITCH-DARPin approachZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 14, 2023 (GLOBE NEWSWIRE) — Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, will present on several of its programs at the 15th Annual Protein & Antibody Engineering European Summit (PEGS Europe), which runs November 14-16 in Lisbon, Portugal. The presentation will focus on the multiple ways Molecular Partners has designed...

Under One Roof: WISeKey International Holding Ltd Unifies Its Operations in GenevaGeneva, November 14, 2023 – WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leader in cybersecurity, digital identity, and Internet of Things (IoT) solutions operating as a holding company, today announced the unification of its operations and affiliated entities under one Geneva roof. Our new headquarters is now located at 58 Avenue Casai, Geneva. Carlos Moreira, CEO of WISeKey noted, “This strategic consolidation in our state-of-the-art facilities enhances collaboration and interaction across our diverse subsidiaries, each a specialist in distinct segments of our expansive technology portfolio. While each subsidiary will continue to operate as a distinct business entity, by centralizing processes, systems, resources, and procedures...